Mr. Ovadya brings nearly two decades of broad experience in corporate finance, accounting, M&A transactions, IPOs, and RTOs. Eran has a professional track record from 1st tier global corporations and significant expertise in public life-science and publicly-traded companies.
Prior to joining NurExone, Eran provided outsourced CFO services to a variety of companies including Silenseed, VVT Medical, Procore, Forrest Innovations, Cannibble and more.
Prior to that, Eran served for over a decade in a variety of finance roles for biotech companies including Gamida Cell, West pharma Israel, Omrix Biopharmaceuticals, a division of Ethicon Biosurgery, a Johnson & Johnson company, Macrocure, and Leap Therapeutics. With these companies and others, Eran played an integral role in NASDAQ IPOs and RTO processes.
Eran holds an MBA, specializing in financing, and a BA in accounting & economics from the Open University, Israel.